Search Results - "GRANOFF, DAN M"

Refine Results
  1. 1

    Review of Meningococcal Group B Vaccines by Granoff, Dan M.

    Published in Clinical infectious diseases (01-03-2010)
    “…No broadly effective vaccines are available for prevention of group B meningococcal disease, which accounts for>50% of all cases. The group B capsule is an…”
    Get full text
    Journal Article
  2. 2

    Binding of Complement Factor H (fH) to Neisseria meningitidis Is Specific for Human fH and Inhibits Complement Activation by Rat and Rabbit Sera by Granoff, Dan M, Welsch, Jo Anne, Ram, Sanjay

    Published in Infection and Immunity (01-02-2009)
    “…Complement factor H (fH), a molecule that downregulates complement activation, binds to Neisseria meningitidis and increases resistance to serum bactericidal…”
    Get full text
    Journal Article
  3. 3

    Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding by Costa, Isabella, Pajon, Rolando, Granoff, Dan M

    Published in mBio (26-08-2014)
    “…The meningococcal 4CMenB vaccine (Bexsero; Novartis) contains four antigens that can elicit serum bactericidal activity, one of which is factor H (FH)-binding…”
    Get full text
    Journal Article
  4. 4

    Fatal Nongroupable Neisseria meningitidis Disease in Vaccinated Patient Receiving Eculizumab by Nolfi-Donegan, Deirdre, Konar, Monica, Vianzon, Vianca, MacNeil, Jessica, Cooper, James, Lurie, Perrianne, Sedivy, Judi, Wang, Xin, Granoff, Dan M, McNamara, Lucy

    Published in Emerging infectious diseases (01-08-2018)
    “…Patients receiving eculizumab have an increased risk for meningococcal disease, but most reported cases are attributable to encapsulated meningococcal strains…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine by Beernink, Peter T, Vianzon, Vianca, Lewis, Lisa A, Moe, Gregory R, Granoff, Dan M

    Published in mBio (18-06-2019)
    “…MenB-4C (Bexsero; GlaxoSmithKline Biologicals) is a licensed meningococcal vaccine for capsular B strains. The vaccine contains detergent-extracted outer…”
    Get full text
    Journal Article
  7. 7

    Complement-Mediated Bactericidal Activity of Anti-Factor H Binding Protein Monoclonal Antibodies against the Meningococcus Relies upon Blocking Factor H Binding by GIUNTINI, Serena, REASON, Donald C, GRANOFF, Dan M

    Published in Infection and Immunity (01-09-2011)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  8. 8

    Combined Roles of Human IgG Subclass, Alternative Complement Pathway Activation, and Epitope Density in the Bactericidal Activity of Antibodies to Meningococcal Factor H Binding Protein by Giuntini, Serena, Reason, Donald C, Granoff, Dan M

    Published in Infection and Immunity (01-01-2012)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  9. 9

    Bactericidal Antibody Responses Elicited by a Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Factor H–Binding Protein and Genetically Attenuated Endotoxin by Koeberling, Oliver, Seubert, Anja, Granoff, Dan M.

    Published in The Journal of infectious diseases (15-07-2008)
    “…Background. Outer membrane vesicle (OMV) vaccines from mutant Neisseria meningitidis strains engineered to overexpress factor H-binding protein (fHbp) have…”
    Get full text
    Journal Article
  10. 10

    Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis by Lewis, Lisa A, Vu, David M, Vasudhev, Shreekant, Shaughnessy, Jutamas, Granoff, Dan M, Ram, Sanjay

    Published in mBio (15-10-2013)
    “…The identification of "factor H binding protein (fHbp)-null" invasive meningococcal isolates and the realization that widespread use of fHbp-based vaccines…”
    Get full text
    Journal Article
  11. 11

    Bactericidal Antibody Responses Induced by Meningococcal Recombinant Chimeric Factor H-Binding Protein Vaccines by Beernink, Peter T, Granoff, Dan M

    Published in Infection and Immunity (01-06-2008)
    “…Factor H-binding protein (fHbp) is a novel meningococcal vaccine candidate that elicits serum antibodies that activate classical complement pathway…”
    Get full text
    Journal Article
  12. 12

    A Newly-Identified Polymorphism in Rhesus Macaque Complement Factor H Modulates Binding Affinity for Meningococcal FHbp by Konar, Monica, Beernink, Peter T, Granoff, Dan M

    Published in PloS one (18-08-2015)
    “…Two meningococcal serogroup B vaccines contain Factor H binding protein (FHbp). Binding of Factor H (FH) to FHbp was thought to be specific for human or…”
    Get full text
    Journal Article
  13. 13

    Complement-Dependent Synergistic Bactericidal Activity of Antibodies against Factor H–Binding Protein, a Sparsely Distributed Meningococcal Vaccine Antigen by Welsch, Jo Anne, Ram, Sanjay, Koeberling, Oliver, Granoff, Dan M.

    Published in The Journal of infectious diseases (01-04-2008)
    “…BackgroundAntibodies to factor H (fH)–binding protein (fHBP), a meningococcal vaccine antigen, activate classical complement pathway serum bactericidal…”
    Get full text
    Journal Article
  14. 14

    Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults by Konar, Monica, Granoff, Dan M.

    Published in Blood (17-08-2017)
    “…Eculizumab, a humanized anti–complement C5 monoclonal antibody (mAb) for treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic…”
    Get full text
    Journal Article
  15. 15

    A Critical Threshold of Meningococcal Factor H Binding Protein Expression Is Required for Increased Breadth of Protective Antibodies Elicited by Native Outer Membrane Vesicle Vaccines by Koeberling, Oliver, Delany, Isabel, Granoff, Dan M

    Published in Clinical and Vaccine Immunology (01-05-2011)
    “…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  16. 16

    Design of Meningococcal Factor H Binding Protein Mutant Vaccines That Do Not Bind Human Complement Factor H by PAJON, Rolando, BEERNINK, Peter T, GRANOFF, Dan M

    Published in Infection and Immunity (01-08-2012)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  17. 17

    Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa by Pajon, Rolando, Fergus, Andrew M, Granoff, Dan M

    Published in PloS one (21-06-2013)
    “…The meningococcal serogroup A (MenA) polysaccharide conjugate vaccine used in Sub-Saharan Africa does not prevent disease caused by MenW or MenX strains, which…”
    Get full text
    Journal Article
  18. 18

    Fine Antigenic Specificity and Cooperative Bactericidal Activity of Monoclonal Antibodies Directed at the Meningococcal Vaccine Candidate Factor H-Binding Protein by Beernink, Peter T, Welsch, Jo Anne, Bar-Lev, Michal, Koeberling, Oliver, Comanducci, Maurizio, Granoff, Dan M

    Published in Infection and Immunity (01-09-2008)
    “…No broadly protective vaccine is available for the prevention of group B meningococcal disease. One promising candidate is factor H-binding protein (fHbp),…”
    Get full text
    Journal Article
  19. 19

    Reconsideration of the Use of Meningococcal Polysaccharide Vaccine by Granoff, Dan M, Pollard, Andrew J

    Published in The Pediatric infectious disease journal (01-08-2007)
    “…In 2005, a quadrivalent meningococcal conjugate vaccine was licensed in the United States for persons aged 11–55 years of age. For children aged 2–10 years…”
    Get full text
    Journal Article
  20. 20

    Does Binding of Complement Factor H to the Meningococcal Vaccine Antigen, Factor H Binding Protein, Decrease Protective Serum Antibody Responses? by Granoff, Dan M, Ram, Sanjay, Beernink, Peter T

    Published in Clinical and Vaccine Immunology (01-08-2013)
    “…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article